{
    "startDate": "2021-01-01",
    "endDate": "2021-06-30",
    "year": "2021",
    "quarter": "Q2",
    "symbol": "BHVN",
    "data": {
        "bs": [
            {
                "label": "Prepaid Expense, Current",
                "concept": "PrepaidExpenseCurrent",
                "unit": "usd",
                "value": 48871000
            },
            {
                "label": "Prepaid Expense, Current",
                "concept": "PrepaidExpenseCurrent",
                "unit": "usd",
                "value": 48871000
            },
            {
                "label": "Derivative liability",
                "concept": "DerivativeLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 15890000
            },
            {
                "label": "Contingently redeemable non-controlling interests",
                "concept": "RedeemableNoncontrollingInterestEquityCarryingAmount",
                "unit": "usd",
                "value": 60000000
            },
            {
                "label": "Trade receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 168637000
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 1242489000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 399132000
            },
            {
                "label": "Common shares, no par value; 200,000,000 shares authorized as of June 30, 2021 and December 31, 2020; 65,240,458 and 60,436,876 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 1618194000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 666580000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 17501000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 10885000
            },
            {
                "label": "Commitments and contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 57501000
            },
            {
                "label": "Total shareholders\u2019 deficit attributable to Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -453877000
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 276630000
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 276630000
            },
            {
                "label": "Marketable securities",
                "concept": "MarketableSecuritiesCurrent",
                "unit": "usd",
                "value": 59840000
            },
            {
                "label": "Non-controlling interests in consolidated subsidiaries",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": -2719000
            },
            {
                "label": "Current portion of mandatorily redeemable preferred shares",
                "concept": "SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent",
                "unit": "usd",
                "value": 62500000
            },
            {
                "label": "Mandatorily redeemable preferred shares, net",
                "concept": "SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent",
                "unit": "usd",
                "value": 133091000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -2214756000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 306267000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 306267000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 60002000
            },
            {
                "label": "Long-term debt",
                "concept": "LongTermDebt",
                "unit": "usd",
                "value": 274138000
            },
            {
                "label": "Obligation to perform R&D services",
                "concept": "bhvn:ObligationForServicesNoncurrent",
                "unit": "usd",
                "value": 55353000
            },
            {
                "label": "Total shareholders' deficit",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -456596000
            },
            {
                "label": "Total shareholders' deficit",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -456596000
            },
            {
                "label": "Inventory",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 64058000
            },
            {
                "label": "Inventory",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 64058000
            },
            {
                "label": "Liability related to sale of future royalties, net",
                "concept": "bhvn:LiabilityForSaleOfFutureRoyaltiesCarryingAmountNoncurrent",
                "unit": "usd",
                "value": 347384000
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 845893000
            },
            {
                "label": "Other prepaid expenses",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 18907000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssets",
                "unit": "usd",
                "value": 110927000
            },
            {
                "label": "Equity method investment",
                "concept": "EquityMethodInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accumulated other comprehensive income",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 280000
            },
            {
                "label": "Total liabilities and shareholders\u2019 deficit",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 845893000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 142405000
            }
        ],
        "cf": [
            {
                "label": "Net cash provided by (used in) investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 160636000
            },
            {
                "label": "(Gain) loss from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 5261000
            },
            {
                "label": "(Gain) loss from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 5261000
            },
            {
                "label": "Issuance of common shares as payment for license and consulting agreements",
                "concept": "IssuanceOfStockAndWarrantsForServicesOrClaims",
                "unit": "usd",
                "value": 4243000
            },
            {
                "label": "Proceeds from issuance of common shares",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 308743000
            },
            {
                "label": "Sales and maturities of marketable securities",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 162293000
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 446187000
            },
            {
                "label": "Prepaid expenses",
                "concept": "IncreaseDecreaseInPrepaidExpense",
                "unit": "usd",
                "value": -28710000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -432716000
            },
            {
                "label": "Payment of principal for finance leases",
                "concept": "FinanceLeasePrincipalPayments",
                "unit": "usd",
                "value": 2514000
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 63868000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 5085000
            },
            {
                "label": "Payments for leasehold improvements",
                "concept": "PaymentsForTenantImprovements",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Interest expense on mandatorily redeemable preferred shares",
                "concept": "InterestExpenseDebtExcludingAmortization",
                "unit": "usd",
                "value": 15985000
            },
            {
                "label": "Trade receivables, net",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 48526000
            },
            {
                "label": "Effect of exchange rate changes on cash, cash equivalents and restricted cash",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": -189000
            },
            {
                "label": "Proceeds from obligation to perform R&D services",
                "concept": "bhvn:ProceedsFromServiceObligation",
                "unit": "usd",
                "value": 100000000
            },
            {
                "label": "Proceeds from the issuance of series B preferred shares",
                "concept": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock",
                "unit": "usd",
                "value": 35170000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherNoncurrentAssets",
                "unit": "usd",
                "value": 79832000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "IncreaseDecreaseInOtherNoncurrentLiabilities",
                "unit": "usd",
                "value": -28138000
            },
            {
                "label": "Proceeds from exercise of share options and employee share purchase plan",
                "concept": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
                "unit": "usd",
                "value": 8643000
            },
            {
                "label": "Payment of term loan commitment fee",
                "concept": "PaymentsOfDebtIssuanceCosts",
                "unit": "usd",
                "value": 3750000
            },
            {
                "label": "Interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 28007000
            },
            {
                "label": "Interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 28007000
            },
            {
                "label": "Other",
                "concept": "ProceedsFromPaymentsForOtherFinancingActivities",
                "unit": "usd",
                "value": 1090000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 11278000
            },
            {
                "label": "Non-cash share-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 74312000
            },
            {
                "label": "Non-cash share-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 74312000
            },
            {
                "label": "Net loss attributable to Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -475587000
            },
            {
                "label": "Net loss attributable to Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -475587000
            },
            {
                "label": "Net loss attributable to Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -475587000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 19046000
            },
            {
                "label": "Interest expense paid-in-kind on long-term debt",
                "concept": "bhvn:NoncashInterestExpenseOnLongTermDebt",
                "unit": "usd",
                "value": 5649000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 1657000
            },
            {
                "label": "Change in obligation to perform R&D services",
                "concept": "bhvn:ChangeInObligationToPerformResearchAndDevelopmentServices",
                "unit": "usd",
                "value": 10205000
            },
            {
                "label": "Other current assets",
                "concept": "IncreaseDecreaseInOtherCurrentAssets",
                "unit": "usd",
                "value": 7051000
            },
            {
                "label": "Payments for intangible assets",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Payment of term loan",
                "concept": "RepaymentsOfLongTermDebt",
                "unit": "usd",
                "value": 1195000
            },
            {
                "label": "Change in fair value of derivatives",
                "concept": "bhvn:FairValueAdjustmentOfDerivativeLiability",
                "unit": "usd",
                "value": 1700000
            },
            {
                "label": "Net increase (decrease) in cash, cash equivalents and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 173918000
            },
            {
                "label": "Other non-cash items",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": -2093000
            }
        ],
        "ic": [
            {
                "label": "Gain (loss) from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 5261000
            },
            {
                "label": "Gain (loss) from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 5261000
            },
            {
                "label": "Other expense, net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -4751000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpenseOther",
                "unit": "usd",
                "value": 15567000
            },
            {
                "label": "Gross profit",
                "concept": "GrossProfit",
                "unit": "usd",
                "value": 106555000
            },
            {
                "label": "Net loss per share attributable to Biohaven Pharmaceutical Holding Company Ltd - basic (in dollars per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": ""
            },
            {
                "label": "Net loss per share attributable to Biohaven Pharmaceutical Holding Company Ltd - basic (in dollars per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -7.48
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 8174000
            },
            {
                "label": "Net loss per share attributable to Biohaven Pharmaceutical Holding Company Ltd - diluted (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -7.48
            },
            {
                "label": "Net loss per share attributable to Biohaven Pharmaceutical Holding Company Ltd - diluted (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": ""
            },
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 514119000
            },
            {
                "label": "Research and development expense",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 184539000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -476521000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -407564000
            },
            {
                "label": "Comprehensive loss attributable to Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -475621000
            },
            {
                "label": "Cost of goods sold",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 30201000
            },
            {
                "label": "Interest expense on mandatorily redeemable preferred shares",
                "concept": "InterestExpenseDebt",
                "unit": "usd",
                "value": 15985000
            },
            {
                "label": "Loss before provision for income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -468313000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -476487000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -476487000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -476487000
            },
            {
                "label": "Weighted average common shares outstanding - basic (shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": "N/A"
            },
            {
                "label": "Weighted average common shares outstanding - basic (shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 63584932
            },
            {
                "label": "Other comprehensive loss, net of tax",
                "concept": "OtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -34000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -476487000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -476487000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -476487000
            },
            {
                "label": "Change in fair value of derivatives",
                "concept": "bhvn:FairValueAdjustmentOfDerivatives",
                "unit": "usd",
                "value": 1700000
            },
            {
                "label": "Total other income (expense), net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -60749000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 329580000
            },
            {
                "label": "Less: comprehensive loss attributable to non-controlling interests",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -900000
            },
            {
                "label": "Less: comprehensive loss attributable to non-controlling interests",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -900000
            },
            {
                "label": "Less: Net loss attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -900000
            },
            {
                "label": "Less: Net loss attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -900000
            },
            {
                "label": "Weighted average common shares outstanding - diluted (shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 63584932
            },
            {
                "label": "Weighted average common shares outstanding - diluted (shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": "N/A"
            },
            {
                "label": "Interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 28007000
            },
            {
                "label": "Interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 28007000
            },
            {
                "label": "Net loss attributable to Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -475587000
            },
            {
                "label": "Net loss attributable to Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -475587000
            },
            {
                "label": "Net loss attributable to Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -475587000
            },
            {
                "label": "Product revenue, net",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 136756000
            }
        ]
    }
}